Procurement Summary
Country : USA
Summary : Bulk Pharma Group B
Deadline : 17 Jan 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 112678477
Document Ref. No. : 75A50325R00003
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in Subpart 12.6 of the Federal Acquisition Regulation (FAR), as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
The Center for the Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR) is seeking the supply of a diverse range of FDA-approved pharmaceuticals. The Contractor, as an independent organization and not as an agent of the Government, shall furnish all labor, materials, supplies, facilities, equipment, transportation and travel necessary to deliver the acceptable pharmaceuticals. The Contractor shall provide brand name or equal product for the following pharmaceuticals. Quantities are detailed in the Statement of work in the attached Request for Proposal.
Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial
Doxycycline Inj, Powder, Lyophilized 100mg/10ml
Levophed (Norepinephrine) 1mg/ml in 4ml amp
Meropenem for injection, 1g powder vial
Sodium Chloride for inj. 0.9% 250 ml flexi bag
Sterile water for injection, preservative free, 10ml solution vial
Active Contract Opportunity
Notice ID : 75A50325R00003
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: ASPR/ORM-SNS
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Jan 03, 2025 10:20 am EST
Original Date Offers Due: Jan 17, 2025 02:00 pm EST
Inactive Policy: 15 days after date offers due
Original Inactive Date: Feb 01, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: GA 30341 USA
Documents
Tender Notice